What standards guide test selection?

Use ISO 10993 risk-based framework to select tests and provide rationale; the report should document why each assay was chosen and reference applicable ISO clauses.

Can the report be signed electronically?

Yes. Electronic signatures are legally valid under the federal ESIGN Act (15 U.S.C. §7001) and state UETA statutes where adopted; ensure intent, consent, attribution, and retention are met.

When is a notarized signature required?

Notarization is rarely required for the report itself, but certain attestations or signature pages may require notarization depending on contract or state law; verify local requirements.

How long must supporting lab data be retained?

Retain supporting test data per quality system and regulatory expectations; FDA device records and quality system documentation are subject to 21 CFR Part 820 retention policies.

Who should sign the report?

A qualified author with relevant credentials (toxicologist, engineer, or regulatory specialist) should sign and date; include role and qualifications for accountability.

What if test results change after submission?

Document changes through controlled revision processes, issue updated reports or addenda, and log decisions in the design history file or quality management system.

Electronic Signature
Templates
Miscellaneous
Biological Evaluation Report

Biological Evaluation Report

This template is fully customizable. Edit the text, fill out the fields, and send it for signature. Give it a try!

Biological Evaluation Report

Report Date:

Client Name: Consultant Name:

WHEREAS

WHEREAS, Client has requested that Consultant perform a biological evaluation, including field surveys, habitat assessment, and preparation of findings and recommendations for the project identified below; and

WHEREAS, Consultant represents that it possesses the professional qualifications, permits, and experience necessary to perform biological studies and to prepare a written Biological Evaluation Report in accordance with applicable professional standards; and

WHEREAS, the parties agree that the scope, payment terms, confidentiality obligations, and governing law set forth herein shall govern Consultant's performance and delivery of the Biological Evaluation Report.

Project Information

Project Name Project Number / ID Project Location (address / legal description) County / Jurisdiction Assessor Parcel Number(s) (APN)

Purpose of Report

Scope of Work

Methodology

Field Survey Dates: From to

Primary Survey Personnel:

Methods employed (check all that apply):

Literature and records review Field survey and habitat assessment Targeted species surveys Remote imagery / GIS analysis

Existing Conditions and Habitat Description

Species and Special-Status Resources

Sensitive species observed or with high potential to occur:

Impact Analysis

Significance determination (select one):

No impact anticipated Less than significant with measures Significant but mitigable Significant and unavoidable

Avoidance, Minimization and Mitigation Measures

Recommendations and Monitoring

Attachments and Supporting Documents

Attachments provided (check all that apply):

Photographic documentation Site maps / Plans Full species inventory Appendices (data sheets, permits)

Certification by Preparer

I hereby certify under penalty of professional sanction that the information contained in this Biological Evaluation Report is true and correct to the best of my knowledge, that surveys were performed by qualified personnel, and that professional standards applicable to biological field studies were followed.

Preparer Name and Title Preparer Qualifications / Certifications

Payment Terms

Fee Amount Payment Schedule Late Payment

Term and Termination

Agreement Start Date: Agreement End Date:

Notice Period for Termination

Confidentiality

Consultant shall treat Client-provided proprietary data and unpublished findings as confidential. Consultant will not disclose Confidential Information to third parties except (i) as necessary to perform the scope of work, (ii) as required by law, or (iii) with Client's prior written consent. Confidential obligations survive termination for a period of .

Limitation of Liability

Consultant's liability for claims arising out of services performed under this Report shall be limited to direct damages and shall not exceed the total fees paid to Consultant for the services described herein. Neither party shall be liable for consequential, incidental, or punitive damages except for willful misconduct or gross negligence.

Governing Law; Dispute Resolution

This Agreement and the interpretation of this Report shall be governed by the laws of the State of . The parties shall attempt in good faith to resolve disputes by negotiation, and if unresolved, submit to mediation prior to pursuing litigation.

Entire Agreement

This Biological Evaluation Report, including its attachments and any executed task orders or exhibits, constitutes the entire agreement between Client and Consultant with respect to the subject matter hereof and supersedes all prior agreements, understandings, and representations, whether written or oral.

Notices

Client Billing / Notice Contact Consultant Contact

Client Printed Name:

By:

Date:

Consultant Printed Name:

By:

Date:

What the Biological Evaluation Report Is and Why It Exists

A Biological Evaluation Report documents the assessment of a medical device or material for potential biological risks, including cytotoxicity, sensitization, irritation, systemic toxicity, and leachables. It summarizes test results, rationale for test selection, risk analysis, and conclusions about biocompatibility for the intended clinical contact. The report typically follows ISO 10993 principles and supports regulatory submissions, product development decisions, and internal risk management. In the U.S. context the document often accompanies FDA premarket submissions or quality system records and serves as evidence of due diligence in safety evaluation.

Why a Clear Biological Evaluation Report Matters

A complete report provides traceable evidence that biological risks were evaluated and mitigated, enabling informed regulatory review and safer product decisions. It reduces review cycles by presenting test rationale, methods, and results in a structured manner and supports compliance with FDA expectations and ISO 10993 best practices.

Who Prepares and Relies on This Report

Stakeholders across product development rely on the report to document risk-based decisions and to demonstrate compliance with applicable standards and regulations.

Regulatory Affairs teams review the report to prepare FDA submissions and ensure alignment with device classification requirements.
Clinical and Safety Engineers use data to confirm design choices and to plan mitigation or additional testing.
Contract manufacturers and testing laboratories reference the report to scope test plans and data collection requirements.

Core Sections Every Professional Report Should Include

A professional Biological Evaluation Report is organized for clarity and traceability. Key sections align to risk-based evaluation steps and make it easier for reviewers to find test rationale, methods, results, and conclusions.

Executive Summary

Concise overview of device, intended use, and high-level conclusion on biocompatibility.

Device Description

Materials, manufacturing process, patient-contacting parts, and exposure duration.

Risk Assessment

Identification of biological hazards, exposure routes, and risk acceptability criteria.

Test Plan & Rationale

Selected assays, acceptance criteria, and justification referencing ISO 10993 and guidance.

Test Methods & Results

Detailed methods, lab reports, raw data summaries, and pass/fail evaluation.

Conclusions & Recommendations

Overall determination, any residual risks, and actions for monitoring or mitigation.

Essential Information Fields to Include

Device Name: Trade and model names

Manufacturer: Legal entity and address

Intended Use: Clinical application and exposure duration

Materials: List of patient-contacting materials

Test Dates: Dates for sample prep and testing

Report Author: Name, title, and qualifications

Step-by-Step: Preparing a Biological Evaluation Report

Follow a structured workflow from scope to conclusion to produce a defensible report that reviewers and auditors can follow easily.

01

Define Scope: Identify device, contact type, and exposure category.
02

Gather Data: Collect material specs, prior testing, and supplier declarations.
03

Select Tests: Choose assays per ISO 10993 risk-based rationale.
04

Compile Findings: Summarize methods, results, and risk conclusions.

Configuring an Online Workflow for the Report

Set up an electronic workflow that mirrors the report review and approval order to preserve auditability and reduce turnaround time.

Field	Configuration
Author Upload	Author role uploads draft and source data
Peer Review	Second reviewer required before QA
QA Approval	Quality signs off on format and completeness
Regulatory Sign-off	Final approval and versioning before release

Where to Send and How Reports Are Routed

Define routing rules so the report moves automatically from authoring through technical review to regulatory sign-off and archival.

Author to Peer: Draft sent to peer reviewer with comments enabled
Peer to QA: Accepted drafts route to quality assurance
QA to Regulatory: QA-approved documents route to regulatory for signature
Archive: Final signed reports are stored in a compliant archive

Distribution and Technical Requirements for eSubmission

Ensure the chosen platform supports tamper-evident signed PDFs, audit logs, and access controls to meet FDA and internal quality requirements.

Formats Supported: PDF/A and DOCX preferred
Authentication: Email link, SMS code, or SSO
Integrations: Link to document management and ERP systems

Typical Timing and Processing Expectations

Turnaround targets depend on the scope of testing and internal review queue positions. Plan timelines early to avoid delays in regulatory submissions.

Draft Preparation:

2–4 weeks depending on data availability

Lab Testing:

2–12 weeks based on assays required

Peer Review:

1–2 weeks for technical review

Regulatory Sign-off:

1 week after QA approval

Submission Buffer:

Allow extra 2–4 weeks for unforeseen data requests

Key Milestones from Scope to Archive

Track these sequential milestones to ensure the report supports submission schedules and compliance review.

01

Scope Defined

Set intended use and testing matrix at project start

02

Samples Prepared

Receive and document samples for testing

03

Testing Complete

Obtain laboratory reports and raw data

04

Final Sign-off

Regulatory signs and releases report to archive

Common Mistakes to Avoid

Incomplete device description that omits exposure duration or contact materials, leading to improper test selection
Missing or poorly referenced lab reports, making results unverifiable for reviewers
Using vendor declarations without traceable supplier documentation or lot numbers
Failing to align the test plan with ISO 10993 and documented risk assessment rationale

Consequences of an Inaccurate or Incomplete Report

Regulatory Delay: Submission hold or additional information requests

Market Risk: Product launch postponement or recall potential

Liability Exposure: Increased litigation or warranty claims

Quality Findings: Internal CAPA and audit observations

Financial Cost: Extra testing and resubmission expenses

Reputation Impact: Loss of customer or regulator confidence

eSignature Vendor Comparison for Signing and Sharing the Report

Choose a signing provider that supports secure PDF signing, audit trails, and applicable compliance (for example HIPAA where health data is included). The table compares starting price and key features; signNow is listed first.

	signNow	DocuSign	Adobe Sign	PandaDoc	HelloSign
Starting Price	$8/user/mo	$15/user/mo	$14/user/mo	$19/user/mo	$15/user/mo
Free Trial	7-day free trial	Varies by plan	Varies by plan	Varies by plan	Varies by plan
Bulk Send	Yes	Yes	Yes	Yes	No
Audit Trail	Yes	Yes	Yes	Yes	Yes
HIPAA Compliant	Yes	Yes	Yes	Varies	Varies

Frequently Asked Questions About Biological Evaluation Reports

Answers to common questions about scope, signatures, retention, and electronic submission for Biological Evaluation Reports.

Need help? Contact support

What standards guide test selection?
Use ISO 10993 risk-based framework to select tests and provide rationale; the report should document why each assay was chosen and reference applicable ISO clauses.
Can the report be signed electronically?
Yes. Electronic signatures are legally valid under the federal ESIGN Act (15 U.S.C. §7001) and state UETA statutes where adopted; ensure intent, consent, attribution, and retention are met.
When is a notarized signature required?
Notarization is rarely required for the report itself, but certain attestations or signature pages may require notarization depending on contract or state law; verify local requirements.
How long must supporting lab data be retained?
Retain supporting test data per quality system and regulatory expectations; FDA device records and quality system documentation are subject to 21 CFR Part 820 retention policies.
Who should sign the report?
A qualified author with relevant credentials (toxicologist, engineer, or regulatory specialist) should sign and date; include role and qualifications for accountability.
What if test results change after submission?
Document changes through controlled revision processes, issue updated reports or addenda, and log decisions in the design history file or quality management system.

be ready to get more

Join over 28 million airSlate SignNow users

Sign Now